Concerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.
from Reuters: U.S. https://ift.tt/2zJqxNH
0 comments:
Post a Comment